COVID-19 Linked to Long-Term Sleep Apnea Risk

A study published in the journal Scientific Reports reveals that individuals who have contracted SARS-CoV-2 face an increased risk of developing new-onset obstructive sleep apnea (OSA) for up to 4.5 years post-infection. Researchers analyzing electronic medical records from the Montefiore Health System for over 910,000 patients found that COVID-19 infection is independently associated with a … Read more

Universal Sarbecovirus Vaccine Shows Promise in First Human Trial

The End of “Reactive” Medicine: How AI is Ending the Pandemic Chase For decades, humanity has played a high-stakes game of cat-and-mouse with viruses. When a new pathogen emerges, scientists rush to sequence it, manufacture a targeted vaccine, and scramble to distribute it—often just as the virus begins to mutate into something new. We see … Read more

Scientists map 239 human-infective RNA viruses to track future outbreak risks

The Hidden Map of Viral Threats: Decoding the RNA Landscape The battle against emerging infectious diseases is often a race against an invisible enemy. A comprehensive new global dataset has recently brought the number of known human-infective RNA virus species to 239. This isn’t just a list; it is a roadmap showing how animal hosts, … Read more

COVID-19 virus not retained in placenta after maternal recovery

Beyond the Infection: Understanding Placental Recovery For a long time, a critical question lingered for clinicians and expectant mothers: does the virus that causes COVID-19 stay hidden in the placenta long after a mother has recovered? Recent findings from Yale researchers, published in JAMA Network Open, provide a significant answer that shifts how we view … Read more

Scientists find unexpected immune pathways for mRNA cancer vaccines

The Evolution of mRNA: From Pandemic Response to Cancer Treatment The global response to the COVID-19 pandemic accelerated a technological leap that is now reshaping oncology. MRNA technology, which provided the blueprint for vaccines like Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax, is moving beyond viral prevention to target some of the most challenging forms of cancer. … Read more

Study finds long COVID leaves a distinct immune signature in the blood

Unlocking Long COVID: New Protein Patterns Offer Hope for Diagnosis and Treatment Recent research is shedding light on the complex biological mechanisms behind Long COVID, identifying distinct protein patterns in the blood that differentiate those still struggling with symptoms months after infection from those who have recovered. A study published in Communications Medicine reveals key … Read more

Do multi-strain probiotics improve long covid symptoms?

Can Probiotics Offer a Path to Long COVID Relief? Emerging Research Explores Gut-Brain Connection The lingering effects of COVID-19, often referred to as long COVID, continue to challenge medical science. While research expands, a growing body of evidence suggests a surprising potential ally in the fight against persistent symptoms: probiotics. New studies are focusing on … Read more

CDC tracks SARS-CoV-2 BA.3.2 global rise and finds early signals in U.S. wastewater

Fresh COVID Variant “Cicada” (BA.3.2) Spreads: What You Need to Know Health officials are closely monitoring a newly emerging COVID-19 variant, BA.3.2, nicknamed “Cicada” due to its prolonged period of undetected circulation. The Centers for Disease Control and Prevention (CDC) recently published a report detailing its spread across the globe and within the United States. … Read more

Study highlights neurological and psychiatric impacts of long COVID

The Long Shadow of COVID: Navigating a Chronic Illness and its Future Nearly three years after the acute phase of the SARS-CoV-2 pandemic subsided, a significant global health challenge remains: Long COVID. Conservative estimates suggest between 80 million and 400 million people worldwide are living with this chronic condition, impacting their quality of life and … Read more

DNA origami vaccine platform shows promise against multiple infectious viruses

Beyond COVID-19: The Next Generation of mRNA and DNA Vaccine Technology The rapid development and deployment of mRNA vaccines during the COVID-19 pandemic marked a turning point in global healthcare. These vaccines, initially administered in December 2020, are estimated to have prevented at least 14.4 million deaths in the first year alone. This success has … Read more